Fused heterocycle polymers represent a cutting-edge frontier in the realm of drug delivery, offering innovative solutions to address challenges in therapeutic efficacy and bioavailability. These polymers, characterized by their unique fused ring structures containing diverse heterocyclic moieties, have garnered significant attention for their promising attributes in tailoring drug release profiles and enhancing targeted delivery.
The strategic design of fused heterocycle polymers allows for the incorporation of specific functionalities, imparting tunable physicochemical properties that influence drug encapsulation, release kinetics, and stability. This versatility enables the creation of tailored drug delivery systems capable of navigating the complex biological milieu with precision. Moreover, the inherent biocompatibility of these polymers enhances their suitability for pharmaceutical applications, minimizing potential adverse effects.
Catalog: CDP23-318-L
MW: 11.7 KDa, 12.7 KDa, 13.7 KDa, 28 KDa, 55 KDa, 65 KDa, 70 KDa, 80.5 KDa, 212 KDa
Catalog: CDP23-348-L
MW: 1 KDa, 2 KDa, 5 KDa, 6 KDa, 8 KDa, 10 KDa, 14 KDa, 17 KDa, 31 KDa, 42 KDa, 50 KDa, 71 KDa, 110 KDa, 140 KDa, 190 KDa, 260 KDa, 326 KDa, 493 KDa, 633 KDa, 727 KDa, 875 KDa, 900 KDa
Catalog: CDP23-349-L
MW: 1.5 KDa, 3 KDa, 4.5 KDa, 7 KDa, 8 KDa, 9.5 KDa, 15 KDa, 18 KDa, 36 KDa, 48 KDa, 50 KDa, 77.5 KDa, 110 KDa
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.